We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOE
1726
DELISTED
Ferro Corporation
FOE
| $1.47M | ﹤0.01% |
96,719
+3,037
| +3% | +$43.5K |
|
1727
Amkor Technology
AMKR
$12.4B
| $1.46M | ﹤0.01% |
126,326
+5,566
| +5% | +$57.4K |
|
1728
Tronox
TROX
$932M
| $1.46M | ﹤0.01% |
79,235
+2,301
| +3% | +$34.2K |
|
|
CSFL
1729
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $1.46M | ﹤0.01% |
56,324
+3,243
| +6% | +$81.4K |
|
|
ASNA
1730
DELISTED
Ascena Retail Group, Inc.
ASNA
| $1.46M | ﹤0.01% |
17,126
+4,830
| +39% | +$464K |
|
1731
AdvanSix
ASIX
$541M
| $1.46M | ﹤0.01% |
53,271
+16,621
| +45% | +$430K |
|
1732
Wayfair
W
$11.2B
| $1.45M | ﹤0.01% |
35,890
+1,399
| +4% | +$55.3K |
|
|
BNCL
1733
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $1.45M | ﹤0.01% |
90,701
+2,879
| +3% | +$48.7K |
|
|
NXGN
1734
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.45M | ﹤0.01% |
95,162
+25,538
| +37% | +$376K |
|
1735
Fox Factory Holding Corp
FOXF
$755M
| $1.45M | ﹤0.01% |
50,453
+20,897
| +71% | +$568K |
|
|
NPKI
1736
NPK International
NPKI
$1.06B
| $1.44M | ﹤0.01% |
177,812
+47,058
| +36% | +$362K |
|
|
ATW
1737
DELISTED
Atwood Oceanics
ATW
| $1.44M | ﹤0.01% |
151,077
+56,785
| +60% | +$634K |
|
1738
Orthofix Medical
OFIX
$477M
| $1.44M | ﹤0.01% |
37,610
+14,216
| +61% | +$526K |
|
1739
Builders FirstSource
BLDR
$7.15B
| $1.43M | ﹤0.01% |
95,778
+4,738
| +5% | +$61.3K |
|
1740
Quanex
NX
$819M
| $1.43M | ﹤0.01% |
70,473
+18,649
| +36% | +$371K |
|
|
HTLF
1741
DELISTED
Heartland Financial USA, Inc.
HTLF
| $1.42M | ﹤0.01% |
28,511
+1,901
| +7% | +$91.7K |
|
1742
Autoliv
ALV
$9.02B
| $1.42M | ﹤0.01% |
19,279
+832
| +5% | +$64.4K |
|
|
GES
1743
DELISTED
Guess Inc
GES
| $1.42M | ﹤0.01% |
127,332
+35,946
| +39% | +$442K |
|
1744
CEVA Inc
CEVA
$910M
| $1.42M | ﹤0.01% |
39,953
+11,682
| +41% | +$404K |
|
|
EGRX
1745
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.42M | ﹤0.01% |
17,088
+4,648
| +37% | +$346K |
|
|
IMPV
1746
DELISTED
Imperva, Inc.
IMPV
| $1.42M | ﹤0.01% |
34,529
+361
| +1% | +$15.1K |
|
1747
1st Source
SRCE
$2.16B
| $1.41M | ﹤0.01% |
30,097
+565
| +2% | +$25.8K |
|
|
LKSD
1748
DELISTED
LSC Communications, Inc.
LKSD
| $1.41M | ﹤0.01% |
56,177
+19,519
| +53% | +$510K |
|
|
UTEK
1749
DELISTED
Ultratech Inc.
UTEK
| $1.41M | ﹤0.01% |
47,591
+12,613
| +36% | +$350K |
|
|
EXPR
1750
DELISTED
Express, Inc.
EXPR
| $1.41M | ﹤0.01% |
7,724
+2,163
| +39% | +$447K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.